Parathyroid hormone: A novel tool for treating bone marrow depletion in cancer patients caused by chemotherapeutic drugs and ionizing radiation
- 1 November 2006
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 244 (1) , 8-15
- https://doi.org/10.1016/j.canlet.2006.02.006
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool sizeThe Journal of Experimental Medicine, 2005
- Parathyroid hormone and leptin – new peptides, expanding clinical prospectsExpert Opinion on Investigational Drugs, 2005
- Regulation of Hematopoietic Stem Cells by the NicheTrends in Cardiovascular Medicine, 2005
- Identification of the haematopoietic stem cell niche and control of the niche sizeNature, 2003
- Osteoblastic cells regulate the haematopoietic stem cell nicheNature, 2003
- Solid-Phase Synthesis of the Biologically Active N-Terminal 1—34 Peptide of Human Parathyroid HormoneBiological Chemistry, 1974
- Hypoplasia of the bone marrow in rats following removal of the parathyroid glandsJournal of Cellular Physiology, 1972
- Calcium Homeostasis and Erythropoietic Control in the RatCanadian Journal of Physiology and Pharmacology, 1971
- Calcium and the Control of Mitosis in the MammalNature, 1967
- The Radioprotective Action of Parathyroid ExtractInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1961